36-2513
|
36-2513. Substances in schedule II A. The following controlled substances are, unless specifically excepted, included in schedule II: 1. Any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by combination of extraction and chemical synthesis: (a) Opium and opiate and any salt, compound, derivative or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, naloxone and naltrexone and their respective salts, but including the following: (i) Raw opium. (ii) Opium extracts. (iii) Opium fluid extracts. (iv) Powdered opium. (v) Granulated opium. (vi) Tincture of opium. (vii) Codeine. (viii) Ethylmorphine. (ix) Etorphine hydrochloride. (x) Hydrocodone. (xi) Hydromorphone. (xii) Metopon. (xiii) Morphine. (xiv) Oxycodone. (xv) Oxymorphone. (xvi) Thebaine. (xvii) Levo-alphacetylmethadol. (b) Any salt, compound, derivative or preparation thereof which is chemically equivalent or identical with any of the substances referred to in subdivision (a) of this paragraph, except that these substances shall not include the isoquinoline alkaloids of opium. (c) Opium poppy and poppy straw. (d) Coca leaves and any salt, compound, derivative or preparation of coca leaves, including cocaine and its optical isomers and any salt, compound, derivative or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine. (e) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrine alkaloids of the opium poppy). 2. Any of the following, including opiates and isomers, esters, ethers, salts and salts of isomers of the following, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation, dextrorphan excepted: (a) Alfentanil. (b) Alphaprodine. (c) Anileridine. (d) Bezitramide. (e) Carfentanil. (f) Dihydrocodeine. (g) Diphenoxylate. (h) Fentanyl. (i) Isomethadone. (j) Levomethorphan. (k) Levorphanol. (l) Metazocine. (m) Methadone. (n) Methadone--intermediate, 4-cyano-2-dimethylamino-4, 4-diphenylbutane. (o) Moramide--intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid. (p) Nabilone. (q) Pethidine (meperidine). (r) Pethidine--intermediate--A, 4-cyano-1-methyl- 4-phenylpiperidine. (s) Pethidine--intermediate--B, ethyl-4-phenylpiperidine- 4-carboxylate. (t) Pethidine--intermediate--C, 1-methyl-4-phenylpiperidine- 4-carboxylic acid. (u) Phenazocine. (v) Phenylacetone. (w) 1-(2-phenylethyl)-4-phenyl-4-acetyloxpiperidine (pepap), including its optical isomers, salts and salts of isomers. (x) Piminodine. (y) Racemethorphan. (z) Racemorphan. (aa) Sufentanil. (bb) Remifentanil. 3. Any material, compound, mixture or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system: (a) Amphetamine and its salts, optical isomers and salts of its optical isomers. (b) Methamphetamine, including its salts, isomers and salts of isomers. (c) Phenmetrazine and its salts. (d) Methylphenidate. 4. Any material, compound, mixture or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation: (a) Amobarbital. (b) Glutethimide. (c) Pentobarbital. (d) Phencyclidine. (e) Phencyclidine immediate precursors: (i) 1-phenylcyclohexylamine. (ii) 1-piperidinocyclohexanecarbonitrile (PCC). (f) Secobarbital. B. The board may except by rule any compound, mixture or preparation containing any substance listed in this section from the application of all or any part of this chapter if the compound, mixture or preparation contains one or more active medicinal ingredients and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiates the potential for abuse. |